December 13, 2017
WELLESLEY, Mass., Dec.13, 2017 – The continuous glucose monitoring market, first introduced in 1999, is seeing strong growth as diabetics, physicians, hospitals and clinics see the benefits these devices can lend to the management of glucose levels, according to a report by BCC Research. The market now includes blood glucose monitors, diabetes test strips, insulin durable and patch pumps, glucose sensors, and transmitters and receivers.
The global market for continuous glucose monitoring equipment is expected to top $20.6 billion by 2022, according to the report Continuous Glucose Monitoring (CGM): Technologies and Global Markets, and enjoy a compound annual growth rate (CAGR) of 10.1%.
“The market for continuous glucose monitoring (CGM) products—defined as transmitters, receivers and glucose sensors—used with these systems is growing at a strong rate as diabetics, physicians, hospitals and clinics come to realize that the use of CGMs provides significant assistance in the management of blood glucose levels, and as insurance plans move to reimburse for use of these devices,” said BCC Research analyst and report author Valerie Kellogg. “The market is strong and growing in double digits.”
Companies mentioned in this report include Abbott Labs, Apple, Ascensia Diabetes Care Holdings, Cellnovo Group, Debiotech, Echo Therapeutics, Glooko, Insulet, Johnson & Johnson, Labstyle Innovations, Medella Health, Medtronic, Nemaura Medical, Novo Nordisk, Onduo, Pharma Tech Solutions, Roche, Sanofi, Tandem Diabetes Care, Unilife and Ypsomed, among others.
Noninvasive Blood Glucose Monitoring: Will the Dream Become a Reality?
Several companies are continuing work toward a noninvasive method of monitoring a person’s blood glucose levels, as the fear of pain, the unattractiveness of sticking your own finger, potentially dirty hands and the social stigma of conducting finger sticks in public all reduce testing compliance and glycemic control. There are a number of hurdles to overcome before such a product is ready for the market, however, including accuracy issues, calibration and potential lag time between a glycemic event and detection by the noninvasive monitor. Further, when such a product is developed, the manufacturer will have to overcome skeptics. Companies working on noninvasive blood glucose monitors include Abbott, Cynoga Medical, Echo Therapeutics, MediWise, Integrity Applications, Medella Health and Verily.
Editors/reporters requesting analyst interviews should contact firstname.lastname@example.org.
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: email@example.com as the source and publisher. Thank you.
Continuous Glucose Monitoring (CGM): Technologies and Global Markets( HLC102C )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email firstname.lastname@example.org or visit www.bccresearch.com/media to request access to our library of market research.